# JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year

> **NCT06930521** · NA · NOT_YET_RECRUITING · sponsor: **Women's College Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Cardiovascular Health
- Breast Cancer
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- Cardio-oncology
- Circulatory and Respiratory Health
- Clinical and Translational Cardiovascular Sciences
- Health Services and Systems - Healthcare Effectiveness &Amp; Outcomes

## Interventions

- **DIAGNOSTIC_TEST:** Intervention - Low Risk Group OR Intermediate Risk Group

## Key facts

- **NCT ID:** NCT06930521
- **Lead sponsor:** Women's College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2029-06
- **Final completion:** 2033-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06930521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06930521, "JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06930521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*